The Impact of the Vaginal Microbiome and Microbial Metabolites on HIV Transmission at the Female Reproductive Tract Epithelial Barrier
American Journal of Reproductive Immunology · 2026
DOI: 10.1111/aji.70312 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, 2026. Verfasst von Brianna Jesaveluk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Discipline and Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Vagina, HIV Infections, Microbiota, Lactobacillus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, NHMRC Senior Research Fellowship, Australian Government Research Training Program Scholarship.
Abstract (Originalsprache)
Despite major advances in biomedical HIV prevention strategies, almost 50% of the 1.3 million new HIV infections in 2024 occurred in women and girls through heterosexual transmission. Choice in HIV prevention modalities is needed throughout a women's lifespan to increase pre‐exposure prophylaxis uptake; however, there is a paucity of topical, on‐demand options. To establish HIV infection, the virus translocates across the epithelial barrier of the upper and lower female reproductive tract to infect CD4 + HIV target cells in the submucosa. The vaginal microbiome modulates this process. Women colonised with an optimal Lactobacillus ‐dominated vaginal microbiota are more protected against acquiring HIV compared to women with a non‐optimal vaginal microbiota including bacterial vaginosis (BV), characterised by an overgrowth of diverse anaerobes and a paucity of beneficial lactobacilli. Optimal Lactobacillus spp. produce ∼1% lactic acid, which in women with a Lactobacillus ‐dominant microbiota acidifies the vaginal pH to less than 4.5, inactivates HIV, exerts antimicrobial effects against BV–associated bacteria, directly inhibits inflammatory responses elicited from cervicovaginal epithelial cells and blocks HIV translocation in vitro. Beneficial properties of optimal vaginal lactobacilli and/or lactic acid can potentially be exploited in vaginal delivery strategies to help prevent vaginal dysbiosis and its adverse sexual and reproductive outcomes including HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Life Sciences Discipline and Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
- Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia.
- Department of Infectious Diseases, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Microbiology, Monash University, Clayton, Victoria, Australia.
ORCID-Profile: Brianna Jesaveluk, Paula Ellenberg, Anna C Hearps, Gilda Tachedjian
Förderung
- National Health and Medical Research Council
- NHMRC Senior Research Fellowship
- Australian Government Research Training Program Scholarship
Zitieren
APA
Jesaveluk, B., Ellenberg, P., Hearps, A. C., & Tachedjian, G. (2026). The Impact of the Vaginal Microbiome and Microbial Metabolites on HIV Transmission at the Female Reproductive Tract Epithelial Barrier. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70312
Vancouver
Jesaveluk B, Ellenberg P, Hearps AC, Tachedjian G. The Impact of the Vaginal Microbiome and Microbial Metabolites on HIV Transmission at the Female Reproductive Tract Epithelial Barrier. American Journal of Reproductive Immunology. 2026. doi:10.1111/aji.70312
BibTeX
@article{Jesaveluk2026,
author = {Jesaveluk, Brianna and Ellenberg, Paula and Hearps, Anna C and Tachedjian, Gilda},
title = {The Impact of the Vaginal Microbiome and Microbial Metabolites on HIV Transmission at the Female Reproductive Tract Epithelial Barrier},
journal = {American Journal of Reproductive Immunology},
year = {2026},
doi = {10.1111/aji.70312}
}
EUVIMED